Data / Form D filings / TheraPten Biosciences Inc.
TheraPten Biosciences Inc.: Form D filings
TheraPten Biosciences Inc., a biotechnology company in Kelowna, British Columbia, Canada, filed 2 Form D notices with the SEC in 2018. The latest, on July 16, 2018, reports $1.5 million sold of a $1.5 million offering to 1 investor.
Find out what TheraPten Biosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 -1865 DILWORTH DRIVE, #705, Kelowna, British Columbia, Canada, V1Y 9
- Phone
- (250) 864-2740
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2016
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1728964
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 16, 2018 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Jun 25, 2018 | sec.gov |
| Jan 24, 2018 | New notice | $500,000 | $500,000 | $0 | 1 | Jan 4, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Athanasios Alevizopoulos | Executive Officer, Director | |
| Yiannis Monovoukas | Director | |
| Harvey Lach | Executive Officer, Director | |
| Kyriakoulis Paganis | Director |
Every Form D from the week of Jul 16, 2018 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TheraPten Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.